parkinson-disease

Documents about parkinson-disease

• Gender differences in non-motor symptoms in Parkinson’s disease: a multicenter longitudinal study#456861IRIS
• The Correlation of Reduction of Levodopa and Non-motor Symptoms of Parkinson's Disease After Deep Brain Stimulation#805053ClinicalTrials.gov
• Music Therapy to Prevent Hospital-acquired Delirium in Parkinson's Disease and Dementia With Lewy Bodies#834426ClinicalTrials.gov
• Clinical Trail of Transcranial MR-guided Focused Ultrasound in the Treatment of Motor Symptoms in Patients With Parkinson' Disease#834880ClinicalTrials.gov
• Connecting the Lab to Everyday Life: The Relevance of Executive Dysfunction to Participation and Quality of Life in Parkinson's Disease (PD) Without Dementia#836492ClinicalTrials.gov
• APA and PAS Training for Gait Initiation in Parkinson's Disease#842120ClinicalTrials.gov
• Quantification of Hsp90 in the Human Brain#849529ClinicalTrials.gov
• Identifying Poor Responders to STN DBS in Parkinson Disease: The Role of Rapid Disease Progression in the First Year in Optimal Responders to Levodopa#625559IRIS
• Myeloid-Driven Inflammation in Prodromal Parkinson's Disease#180151bioRxiv / medRxiv
• Microglial Foxo3 shapes dopaminergic vulnerability in Parkinson disease#298200bioRxiv / medRxiv
• Correlation Between Idiopathic Parkinson's Disease and Diabetes Mellitus#407866ClinicalTrials.gov
• Deep Brain Stimulation and Digestive Symptomatology#803838ClinicalTrials.gov
• The Safety of Remote DBS Programming System#829385ClinicalTrials.gov
• Stimulation settings in subthalamic nucleus deep brain stimulation for parkinson's disease - a retrospective single-center observational study#620212Europe PMC
• Real-World Safety and Effectiveness of 24-Hour Foslevodopa/Foscarbidopa in Parkinson's Disease: ROSSINI Study 6-Month Interim Results#642369Europe PMC
• Frontal subcortical executive dysfunction and minor hallucinations in Parkinson's disease are linked to sensitivity to somatomotor conflicts#664951Europe PMC
• A Study To Evaluate the Safety and Efficacy of Human Neural Stem Cells for Parkinson's Disease Patient#811601ClinicalTrials.gov
• Quantitative Assessment of Training Effects Using EKSOGT Exoskeleton in Quantitative Assessment of Training Effects Using EKSOGT Exoskeleton in Parkinson Disease Patients#835724ClinicalTrials.gov
• PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706#849187ClinicalTrials.gov
• A General Anesthesia Regimen for DBS Surgery in Patients With PD#851673ClinicalTrials.gov
• The SUSTAIN Study Compares the Effects of Sustained and Immediate-release Pramipexole on the noctUrnal Symptoms of paTients With Advanced ParkInsoN's Disease Who Also Take L-Dopa#862982ClinicalTrials.gov
• A PET Brain Imaging Study of mGluR5 in Subjects With Neuropsychiatric Conditions#861087ClinicalTrials.gov
• Freezing of Gait in Parkinson's Disease: A Heterogeneous Phenomenon Across Assessment Tools#273302Europe PMC
• Idebenone Treatment of Early Parkinson's Diseasesymptoms#844124ClinicalTrials.gov
• Kinesia 360 Parkinson's Monitoring Study#854142ClinicalTrials.gov
• HyCoSwin-PD: An explainable hybrid ConvNeXtV2-Swin transformer framework for Parkinson's disease detection from neuroimaging#5355Europe PMC
• Safety, Tolerability, and Pharmacokinetics of Exidavnemab in Patients With Parkinson's Disease and Patients With Multiple System Atrophy#813402ClinicalTrials.gov
• Blood Lactate Concentrations With and Without Exercise in Parkinson's Disease and Multiple Sclerosis Patients#850969ClinicalTrials.gov
• Clinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/Disease#854268ClinicalTrials.gov
• Efectividad de la coordinación dinámica como ejercicio cognitivo sobre la velocidad de la marcha en pacientes con Parkinson#374200Gestión del Repositorio Documental de la Universidad de Salamanca
• Structural and functional magnetic resonance imaging abnormalities and plasma GLP-1 levels in Parkinson's disease with cognitive impairment#5357Europe PMC
• Unravelling the multi-target mechanism of methoxylated flavonoids in Parkinson's disease: Insights from network pharmacology and molecular dynamics#123357Europe PMC
• Hyphenated Mass Spectrometry-based Strategies for Characterizing Oligomers of alpha-Synuclein in Parkinson’s Disease#241329Yoda MOAI Feed
• Comparing neural correlates of gait during forward and backwards walking in individuals with mild to moderate Parkinson's disease#466377SUNScholar
• 42 U.S.C. § 284f — Parkinson’s disease#595168US Code (LII)
• Study on Preliminary Safety and Efficacy of the ARC-IM Therapy to Alleviate Locomotor Deficits in People With Parkinson's Disease#804440ClinicalTrials.gov
• Bladder Complaints in Parkinson's Disease Effectiveness of Pelvic Floor Muscle Exercises and Electrical Stimulation#804448ClinicalTrials.gov
• Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia#805841ClinicalTrials.gov
• A Phase 2b Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa#842026ClinicalTrials.gov
• A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment#850024ClinicalTrials.gov
• Clock and Narcolepsy Genetic Variants and the Effects of Stalevo® (Levodopa/Carbidopa/Entacapone) on Sleep Disorders in Parkinson's Disease#860471ClinicalTrials.gov
• Physiopathologie et prise en charge de la douleur dans la maladie de Parkinson#137368HAL (France)
• Interest of Continuous Subcutaneous Apomorphine in Parkinsonian Patients at the End of Life#834430ClinicalTrials.gov
• Preliminary Study of the Quality of the Oral Flora in Parkinson's Patients#857386ClinicalTrials.gov
• Telehealth Allied Health Care With People Who Have Parkinson's Disease Living in Rural Nevada and Wyoming#810868ClinicalTrials.gov
• Exploration of Mesocorticolimbic Pathway in Impulse Control Disorders in Parkinson's Disease: Study Using Tensor Diffusion Imaging and Tractography.#833864ClinicalTrials.gov
• Feasibility and Preliminary Effects of the Walking Tall App for Home-Based Gait Training in Parkinson's Disease: A Pilot Study#841616ClinicalTrials.gov
• Two Resistance Training Protocols to Reduce the Risk of Falls in Parkinson's Disease#850975ClinicalTrials.gov
• Responding to care delivery challenges for Parkinson’s disease: an ethnographic study of an integrated Parkinson’s Hub#221341OSF
• Non-invasive VNS for Parkinson's Gait#857174ClinicalTrials.gov